Penobscot Investment Management’s GSK GSK Stock Holding History

Penobscot Investment Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,112	Closed	-$242K	–	184
2019 Q4	$242K	Sell	4,112 -669	-14%	-$37.2K	0.05%	182
2019 Q3	$255K	Hold	4,781	–	–	0.05%	177
2019 Q2	$239K	Hold	4,781	–	–	0.05%	184
2019 Q1	$250K	Buy	+4,781	New	+$239K	0.05%	179
2015 Q1	–	Sell	-4,900	Closed	-$262K	–	187
2014 Q4	$262K	Hold	4,900	–	–	0.08%	169
2014 Q3	$282K	Hold	4,900	–	–	0.09%	147
2014 Q2	$328K	Hold	4,900	–	–	0.11%	143
2014 Q1	$327K	Hold	4,900	–	–	0.12%	132
2013 Q4	$327K	Hold	4,900	–	–	0.12%	134
2013 Q3	$307K	Hold	4,900	–	–	0.12%	129
2013 Q2	$306K	Buy	+4,900	New	+$311K	0.13%	124

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Penobscot Investment Management's GSK Position: Q1 2020 in Review

Penobscot Investment Management sold out of GSK (GSK) in Q1 2020, closing a stake of 4,112 shares — an estimated $242K sold.

Penobscot Investment Management first reported a position in GSK in Q2 2013 and held it in 11 quarters. The position peaked at $328K in Q2 2014. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

Penobscot Investment Management reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
Penobscot Investment Management sold 4,112 GSK shares in Q1 2020, an estimated $242K.
Penobscot Investment Management first reported a position in GSK in Q2 2013 and held it in 11 quarters.
Penobscot Investment Management's GSK position peaked at $328K in Q2 2014.
817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Penobscot Investment Management's 13F filing for Q1 2020, filed 7 May 2020.